Alnylam Pharmaceuticals
Alnylam appoints Sara Nochur as VP, regulatory affairs
Published in Patient Care Law Weekly, July 16th, 2006
Nochur has extensive industry experience in the areas of regulatory affairs and overall drug development. At Alnylam, she will be responsible for leading the global regulatory strategy for the company's development-stage programs and overseeing regulatory operations, and will be a member of the management team.
"Sara is an outstanding addition to the Alnylam team," said John Maraganore, PhD, president and CEO of Alnylam Pharmaceuticals. "Her extensive product development and regulatory experience will be an...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Patient Care Law Weekly
More Articles from Patient Care Law Weekly
- American Journal of Preventive Medicine
New study investigates link between seat belt laws and racial disparities in seat belt use - BioVeris
BioVeris reports loss of $0.27 per common share - Enzo Biochem
Enzo Biochem reports results for third fiscal quarter - European Society for Human Reproduction and Embryology
Identity fraud a growing concern among clinics providing in vitro fertilization procedures - European Society for Human Reproduction and Embryology
New method of testing eggs for abnormalities could solve problems of embryo freezing - Injury Prevention
Stalking poses serious public health problem - More from this issue of Patient Care Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
